The Government of Nepal (GoN) has prioritized private sector investment in health infrastructure particularly tertiary hospital and pharmaceutical manufacturing. Nepal has specifically identified the collaboration need between public and private sector for delivery of health services to outperform on its health indicator. Nepal has a relatively large population of 29 million but significant proportion of medicine and health care supply is met by way of imports. There are untapped opportunities for large scale pharmaceutical manufacturers to fill the supply gaps by introducing new technologies and taking the pharmaceutical industry to a higher level. In addition to this, Government of Nepal has also emphasized on promotion of Ayurvedic health care through various herbs and minerals which Nepal abundantly possess. This sector awaits large scale investment for commercialization of Ayurvedic medicines which can promote Nepal as a hub for tradition medical care system of South Asia.